KEYWORDS 16 MACF1, bone development, bone formation, mesenchymal stem cells, osteogenic 17 differentiation, cytoskeleton, SMAD7 18 2 ABSTRACT 19
INTRODUCTION 32 mesenchyme, we identified essential roles of MACF1 in regulating osteogenic differentiation 79 and bone formation in mice. We show that MACF1 is essential for early stage bone 80 development, loss of MACF1 in MSCs retards bone development and further impairs bone 81 properties and bone strength. In vitro experiments demostrate that MACF1 is essential for 82 maintaining the cytoskeleton in differentiating MSCs, loss of MACF1 disorganizes the 83 cytoskeleton and inhibit osteogenic differentiation. In addition, we show that MACF1 directly 84 interacts with SMAD7 and facilitates SMAD7 nuclear translocation to initiate downstream 85 osteogenic pathways. By coupling the results obtained, we have identified key roles of 86 MACF1 in maintaining osteogenic differentiation and bone formation, and advanced the 87 potential for exploiting MACF1 as a new therapeutic target for degenerative bone diseases 88 such as osteoporosis.
89

Results
90
Mesenchymal deletion of MACF1 91 MACF1 is a large structural protein (Bernier et al., 1996; Leung et al., 1999) . Previous 92 studies show that conventional inactivation of the Macf1 gene leads to teratogenicity and 93 lethality during development (Chen et al., 2006 ), suggesting MACF1 is crucial for embryo 94 development in mice. In order to study the in vivo involvement of MACF1 in bone 95 development and formation, we utilized the Cre/Loxp technology and generated a 96 genetically modified mouse model in which the Macf1 gene was specifically deleted in 97 mesenchymal stem cells (Flox, Macf1 f/f ; cKO, Macf1 f/f ;Prx1 Cre/+ ) ( Figure EV1A and S1B). 98 Similar to those conditional MACF1 deficient mice generated using other Cre lines, 99 mesenchymal deletion of MACF1 did not significantly affect body length or body weight in 100 neonates ( Figure 1A , Figure EV1C ) (Goryunov et al., 2010) , and offsprings were obtained Loss of MACF1 weakens bone properties in adult mice 140 Bone forming cells derived from mesenchymal stem cells are responsible for bone 141 matrix synthesis and mineralization (Hilton, 2014) , and finally form the mineral structure that 142 supports bone functions. To investigate the involvement of MACF1 on bone phenotype 143 during adulthood, bone properties in MACF1 deficient mice were tested. Firstly, 3-month old 144 mice were subjected to dual energy X-ray absorptiometry (DEXA) scanning, the results 145 showed that mineral density was lower in both femur and third lumbar vertebra (Figure 2A) , 146 bone mineral content and bone volume were also lower ( Figure EV3A ). 147 Next, distal femur from 6-week old male mice were scanned and reconstructed by 148 microCT. The results showed that in cKO mice, bone mineral content and mineral density 149 were lower ( Figure 2B and 2C), manifest as decreased trabecular number, thickness and 150 increased trabecular spacing ( Figure 3D ), indicating that MACF1 deletion decreased bone 151 mass, and degenerated bone microarchitecture. In addition, to known mechanical properties 152 of the bone, freshly-isolated femora were subjected to 3-point bending test. We found in 153 cKO group not only reduced maximum compression stress and compression strain, but also 154 reduced Young's elastic modulus ( Figure 3E ), suggesting that toughness and strength of the 155 bone were weakened in cKO mice. 156 Bone microenvironment changes with age, and accordingly, the regulation of MSCs 157 osteogenic differentiation varies as well. To confirm age-related phenotypes of the MACF1 158 deficient mice, mice older than peak bone mass age (around 6 month) were examined. 159 MicroCT analysis of 7-month old distal femur showed that in cKO mice, bone mass and bone 160 volume were significantly lower than those in Flox mice ( Figure 2F ), together with 161 deteriorated trabecular microarchitecture ( Figure EV3B ). Further, H&E staining of FFPE 162 femur sections showed that in 12-month mice, trabecular bone volume of cKO mice was still 163 lower ( Figure 2G ), and marrow adipocyte number increased in MACF1 deficient mice 164 ( Figure EV3C ). It is worth noting that, with increased age, BV/TV disparity between Flox and 165 cKO mice increased from 23.9% at 6w to 35.7% at 12m ( Figure 2C , 2F and 2G), suggesting 166 that loss of MACF1 impairs bone properties more seriously in aged mice. Together, these 167 results suggest that MACF1 positively regulates bone mass and bone quality in mice, and 168 that loss of MACF1 confers risk for osteoporosis and fracture.
169
MACF1 is required for bone formation 170 Osteoblasts and osteoclasts are two main cell types in mature bone tissue that 171 synthesize or decompose bone matrix to coordinate bone remodeling. To further understand 172 the behavior of MACF1 in bone development, histochemistry approaches were utilized. 173 Firstly, to differentiate mineralized bone from osteoid that undergoing rapid bone growth, 174 undecalcified femur sections (plastic sections) from 6-week old male mice were prepared.
175
The Goldner's trichrome staining results showed that in addition to porotic and lesser 176 trabeculae, the cKO mice also showed atypical accumulated osteoid on surfaces of both the Lastly, to see the dynamic action of MACF1 on bone formation, mice at 6-week old and 189 3-month old were double-labeled with calcein, respectively. Fluorescence imaging of plastic 190 sections showed that, regardless of mice age, femoral mineral apposition was slower in cKO 191 mice ( Figure 3E and S4B). Bone histomorphometric analysis further revealed that matrix 192 mineralization and bone formation on bone surfaces were also slower ( Figure 3F and S4B).
193
These data suggest that MACF1 is required for bone formation in mice; insufficient MACF1 194 shifts the balance of bone remodeling and finally impairs bone formation. Figure 5E ), suggesting impaired osteogenic differentiation capability upon MACF1 249 deletion. These data indicate that MACF1 is necessary for maintaining osteogenic 250 differentiation, and lack of MACF1 would impairs osteogenic functions in MSCs.
195
Loss of MACF1 disorganizes the cytoskeleton in MSCs
251
MACF1 interacts with SMAD7 in MSCs 252
To explore novel downstream molecules that interact with MACF1 to regulate 253 osteogenic differentiation, we performed iTRAQ-labeled proteomics experiment using 254 MC3T3-E1 preosteoblasts. First we co-immunoprepacited cell lysate using anti-MACF1 255 antibody, and confirmed immunoprecipitation capability of the anti-MACF1 antibody ( Figure   256 6A, S7A and S7B). Next, the IP products were labeled with iTRAQ reagent and subjected to 257 liquid chromatography followed by tandem mass spectrometry (LC-MS/MS) analysis.
258
Unique peptide analysis showed that there were more than 60 proteins interacting with 259 MACF1 in MC3T3-E1 cells, among which 5 were transcription factors (TFs), i.e., BHLHE40, 260 HES1, REL, SMAD7, ZFP748 ( Figure 6B ). To further verify the involvement of these TFs in 261 osteogenic differentiation, the ToppGene database was used to predict their potentials in 262 osteogenic regulation, and highlighted SMAD7 as a most likely transcription factor in 263 osteogenic regulation (data for ZFP748 not found) ( Figure 6C , S7C and S7D). In addition, 264 qPCR analysis revealed that in MC3T3-E1 cells, Smad7 still had relatively high abundance, 265 and in Macf1 knockdown cells, Smad7 levels was also lower ( Figure 6D ). Lastly, we isolated 266 MSCs from wild type mice and performed co-IP to test SMAD7-MACF1 interaction in MSCs. 267 The results showed that SMAD7 was detectable in the immunoprecipitated product, 268 indicating interaction of MACF1 and SMAD7 in MSCs ( Figure 6E ). Besides, 269 immunofluorescence showed from the perspective of intracellular distribution co-localization 270 of MACF1 and SMAD7, which in turn confirmed the Co-IP result ( Figure 6F ).
271
On the basis of MACF1-SMAD7 interaction, to further clarify their regulatory pattern in Figure 7A ). 296 Next, the transfection efficiency was examined. Immunofluorescence images showed 297 that, 12 h after transfection, level of cellular SMAD7 increased, in cells transfected with 298 conventional plasmid, SMAD7 distributed mostly within the cytoplasm, while in cells 299 transfected with NLS-carrying plasmid, SMAD7 concentrated mostly within the nucleus 300 ( Figure 7B ). Then, we explored the effects of SMAD7 overexpression on osteogenic In this study, we identified MACF1 as a key regulator that controls osteogenic functions 319 in mice. We show that MACF1 is necessary for bone development and formation. Loss of 320 MACF1 decreases bone mass and quality in adult mice, which confers risk for degenerative 321 bone diseases such as fracture. In addition, MACF1 stabilizes the microtubule cytoskeleton 322 and controls focal adhesion morphology and regulates osteogenic differentiation in MSCs.
323
Although the role of MACF1 in material transportation has been reported, a novel 324 transcriptional factor SMAD7 that interacts directly with MACF1 is identified until this study, 325 which initiates and promotes downstream osteogenic pathways. Our findings provide a new 326 mechanism for understanding osteogenic differentiation and bone formation regulation, and 327 identified MACF1 as a potential therapeutic target for degenarative bone diseases such as presenting its positive roles in osteogenic regulation (Li et al., 2014) . We noticed that this 380 may be due to its subcellular localization, but the nuclear roles of SMAD7 are still unknown.
381
On the one hand, SMAD7 exists simultaneously in the cytoplasm and nucleus in different subsequent test, femora were secured to the lower supporting pins (span: 9 mm, fillet radius: 513 1 mm) one by one. After preloaded with 1N for 5 s, the tissues were loaded to failure at 1.5 514 mm/min, and load-displacement curves were collected. The inner and outer diameters of 515 the loaded femora were measured using a 3D digital microscope (Hirox KH-8700, Japan).
516
Mechanical parameters were acquired using a built-in software and a previous reported 517 method (Sharir et al., 2008) . 
527
For plastic embedded sections, 6-week-old mice were injected intraperitoneally with calcein 528 (10 mg/kg) 10 days and 2 days prior to euthanasia, respectively. Femora were then collected 529 and fixed, and embedded in gradient methyl methacrylate after conventional tissue 530 dehydration and clearing. Sections (~20 μm) were prepared using the EXAKT 300CP tissue 531 cutting systems and stained using modified Goldner's trichrome staining method (Gruber, 
